Alexion Pharmaceuticals
Simon Lambden is an accomplished medical professional with extensive experience in executive roles, particularly in the pharmaceutical and biotechnology sectors. Currently serving as Executive Medical Director at Alexion Pharmaceuticals, Simon leads translational medicine efforts and has implemented a comprehensive structure for clinical development. As an Expert at Primary Venture Partners, Simon provides strategic advice to early-stage businesses and investment teams. Additionally, Simon holds the title of Future Leader in Innovation, Enterprise and Research at The Academy of Medical Sciences while conducting post-doctoral research at the University of Cambridge. Previous roles include Chief Medical Officer at Inotrem SA, Founding Director at LKBD Consulting Limited, and Consultant in Intensive Care Medicine at Cambridge University Hospitals NHS Foundation Trust. Simon's educational background includes an M.D. and MBBS from the University of London and a PhD in Vascular Biology from Imperial College London, complemented by a certificate in Gene Therapy from Harvard Medical School.
This person is not in any offices
Alexion Pharmaceuticals
45 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.